Hereditary Cancer in Clinical Practice

Papers
(The H4-Index of Hereditary Cancer in Clinical Practice is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
CDKN2A germline alterations and the relevance of genotype-phenotype associations in cancer predisposition41
Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium27
Can harmful lifestyle, obesity and weight changes increase the risk of breast cancer in BRCA 1 and BRCA 2 mutation carriers? A Mini review22
Cytotoxic and targeted therapy for BRCA1/2-driven cancers13
Genetic susceptibility to hereditary non-medullary thyroid cancer12
Danish guidelines for management of non-APC-associated hereditary polyposis syndromes10
Population or family history based BRCA gene tests of breast cancer? A systematic review of economic evaluations10
Progress of HOTAIR-microRNA in hepatocellular carcinoma10
Current status of inherited pancreatic cancer9
Efficacy of different neoadjuvant treatment regimens in BRCA-mutated triple negative breast cancer: a systematic review and meta-analysis9
Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing9
Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system9
0.058542013168335